Preoperative Neutrophil: Lymphocyte Ratio, Platelet: Lymphocyte Ratio, and C-Reactive Protein Levels Predictive Value in Determining the Severity of Breast Mass
Publish place: IRANIAN JOURNAL of PATHOLOGY، Vol: 17، Issue: 4
Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 173
This Paper With 6 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJP-17-4_004
تاریخ نمایه سازی: 30 آبان 1401
Abstract:
Background & Objective: Female breast cancer is one of the most prevalent malignancies among women. The critical step in managing breast cancer is to diagnose it accurately. Hence, peripheral blood-based tests are one of the most favorable and less invasive methods to study. Recent studies investigated and evaluated the inflammation parameters such as neutrophil: lymphocyte ratio (NLR), the platelet: lymphocyte ratio (PLR), and the C-reactive protein (CRP) levels. The elevation in mentioned parameters was proposed as a key factor in cancer progression. The main goal of this study was to investigate the association of NLR, PLR, and CRP levels in patients with breast lesions.Methods: The NLR, PLR, and CRP levels were calculated from ۲۰۰ female patients with either benign or malignant lesions.Results: The cut-off values of NLR, PLR, and CRP were ۱.۲۴, ۹۶, and ۱۰.۳۶ mg/L, respectively. A significant difference in NLR (P<۰.۰۰۱), PLR (P<۰.۰۰۱), and CRP levels (P<۰.۰۰۱) were observed between the two major studied cohorts.Conclusion: Elevated NLR, PLR, and CRP levels could predict the presence of malignancy. In addition to the low cost and properties of the mentioned methods, utilization of this data could facilitate and improve clinical decision-making for treatment.
Keywords:
Authors
Aida Alizamir
Department of Pathology, Hamadan University of Medical Sciences, Hamadan, Iran
Sakineh Dehghan Azad
Department of Pathology, Hamadan University of Medical Sciences, Hamadan, Iran
Azar Pirdehghan
Department of Community Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
Arash Moradi
Department of Medical Biotechnology, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :